Ganeden Biotech, Inc.
Records under this name other than the patents Ganeden Biotech, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 16 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,854,927 | Methods and compositions for the dietary management of autoimmune disorders Term ended Term ended Feb 11, 2026 · USPTO record | Term ended | Term ended Feb 11, 2026 | USPTO record |
| US 8,409,591 | Methods and compositions for the dietary management of autoimmune disorders Term ended Term ended May 10, 2025 · USPTO record | Term ended | Term ended May 10, 2025 | USPTO record |
| US 7,700,093 | Methods for increasing lactose digestion Term ended Term ended May 1, 2025 · USPTO record | Term ended | Term ended May 1, 2025 | USPTO record |
| US 9,220,736 | Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption Term ended Term ended Dec 3, 2022 · USPTO record | Term ended | Term ended Dec 3, 2022 | USPTO record |
| US 8,821,854 | Methods for inhibiting microbial infections associated with sanitary products and for enhancing sanitary product degradation Term ended Term ended Aug 31, 2022 · USPTO record | Term ended | Term ended Aug 31, 2022 | USPTO record |
| US 8,568,743 | Inactivated bacterial cell formulation Lapsed on the fee record Ended Oct 29, 2021 · USPTO record | Lapsed on the fee record | Ended Oct 29, 2021 | USPTO record |
| US 8,568,744 | Inactivated bacterial cell formulation Lapsed on the fee record Ended Oct 29, 2021 · USPTO record | Lapsed on the fee record | Ended Oct 29, 2021 | USPTO record |
| US 9,757,442 | Inactivated bacterial cell formulation Lapsed on the fee record Ended Sep 12, 2021 · USPTO record | Lapsed on the fee record | Ended Sep 12, 2021 | USPTO record |
| US 8,343,484 | Methods for increasing lactose and fructose digestion Term ended Term ended Aug 14, 2021 · USPTO record | Term ended | Term ended Aug 14, 2021 | USPTO record |
| US 7,713,726 | Inhibition of pathogens by probiotic bacteria Term ended Term ended Jul 31, 2021 · USPTO record | Term ended | Term ended Jul 31, 2021 | USPTO record |